Phase Watch
Macro Risklow0 of 9 breached
updated 14:21 UTC
SHILLER CAPE
—
thr 42conf low
SP500 TOP 5 WEIGHT %
—
thr 32conf low
NVDA FWD P/E
—
thr 45conf low
NVDA YoY REV GROWTH %
—
thr 30conf low
SP500 < 200DMA
—
conf low
POLY: AI BUBBLE %
—
thr 30conf low
HY OAS (bps)
—
thr 500conf low
HYPERSCALER CAPEX CUT (30d)
—
conf low
IG OAS (bps, proxy)
—
thr 150conf low
Watchlist
CGTXCognition Therapeutics, Inc.
FINE
$1.12-0.9%
runway 17 mo10-Q · 2mo old
short9.1%·6.9 d2c
CLYMClimb Bio, Inc.
FINE
$13.08+3.3%
runway 44 mo10-Q · 2mo old
short7.4%·2.6 d2c
Watchlist Filingsshowing 30 most recent
  • Jun 24CGTX8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 22CGTX4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 22CGTX4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 22CGTX4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 22CGTX4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 22CGTX4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 18CGTX8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 12CLYM8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 12CLYM424B5ACT
    Prospectus / offering filed (active dilution). filing →
    dilution_riskoffering
  • Jun 11CLYM8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 09CLYM424B3ACT
    Prospectus / offering filed (active dilution). filing →
    dilution_riskoffering
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM4INFO
    4 filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 08CLYM8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 05CLYM8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • Jun 04CGTX8-KINFO
    8-K filed (LLM summary unavailable: BadRequestError). filing →
  • May 29CLYMS-3ATTN
    S-3 shelf registration filed (potential future dilution). filing →
    dilution_risk
  • May 21CGTX8-KINFO
    Cognition Therapeutics, Inc. (CGTX) filed an 8-K dated May 21, 2026. The excerpt provided contains only the cover page and XBRL header metadata (company identity, incorporation state, file number, address). No substantive event details, item disclosures, or material developments are described in the available text; the underlying triggering event and its content are not visible in this excerpt. filing →
    other
  • May 08CGTX10-QINFO
    10-Q periodic report filed. filing →
  • May 07CGTX8-KINFO
    Cognition Therapeutics, Inc. (CGTX) filed an 8-K dated May 7, 2026. The excerpt provided contains only the cover page and XBRL header metadata (entity identifiers, address, incorporation state). No substantive disclosures, events, or items are visible in the supplied text; the content of the triggering event(s) is not present in this excerpt. filing →
    other
  • May 07CLYM10-QINFO
    10-Q periodic report filed. filing →
  • May 07CLYM8-KINFO
    Climb Bio, Inc. (CLYM) filed an 8-K dated May 7, 2026. The excerpt provided contains only the cover page and XBRL header metadata; the substantive body of the filing (items reported, exhibits, and disclosure details) is not included in the excerpt. The specific nature of the reported event cannot be determined from the available text. filing →
    other
  • May 05CLYM8-KINFO
    Climb Bio, Inc. (CLYM) filed an 8-K dated May 5, 2026. The excerpt provided contains only the cover page metadata (registrant name, state of incorporation: Delaware, file number: 001-40708, EIN: 83-2273741). The substantive content of the filing (items reported, exhibits) is not included in the excerpt, so the specific nature of the disclosure cannot be determined. filing →
    other
  • May 04CGTX4INFO
    CFO John Brendan Doyle received a grant of stock options or equity award at CGTX (Cognition Therapeutics) on 05/01/2026 filing →
    insider_grant
  • Apr 29CLYM4INFO
    RA Capital Management, L.P. (Director & 10% Owner) filed a Form 4 for CLYM (Climb Bio, Inc.) with earliest transaction date 04/29/2026; full transaction details not fully visible in the provided excerpt. filing →
    other
Watchlist Catalysts
0 tracked
no catalysts tracked yet
add rows to the catalysts table (see README)
Watchlist Trials
8 active
  • P2CGTXRECRUITING
    Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder clinicaltrials.gov →
    enrollment ?
    T-4d
  • P2CGTXACTIVE NOT RECRUITING
    A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease clinicaltrials.gov →
    enrollment ?
    T-278d
  • EP1CLYMACTIVE NOT RECRUITING
    A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers clinicaltrials.gov →
    enrollment ?
    +87d
  • P1CLYMRECRUITING
    A Phase 1 Study of CLYM116 in Normal Healthy Volunteers clinicaltrials.gov →
    enrollment ?
    T-4d
  • P1CLYMRECRUITING
    A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) clinicaltrials.gov →
    enrollment ?
    T-278d
  • P1/2CLYMRECRUITING
    A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) clinicaltrials.gov →
    enrollment ?
    T-400d
  • P1/2CLYMNOT YET RECRUITING
    A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) clinicaltrials.gov →
    enrollment ?
    T-431d
  • P2CLYMRECRUITING
    A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy clinicaltrials.gov →
    enrollment ?
    T-461d